Provided by Tiger Trade Technology Pte. Ltd.

Arcturus Therapeutics Ltd.

7.64
-0.2700-3.41%
Volume:477.77K
Turnover:3.50M
Market Cap:217.07M
PE:-3.10
High:7.70
Open:7.51
Low:6.81
Close:7.91
52wk High:24.17
52wk Low:5.85
Shares:28.41M
Float Shares:26.28M
Volume Ratio:2.46
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4611
EPS(LYR):-2.9978
ROE:-27.43%
ROA:-15.00%
PB:0.97
PE(LYR):-2.55

Loading ...

Arcturus Therapeutics Holdings Inc : Citigroup Cuts Target Price to $7 From $9

THOMSON REUTERS
·
Jan 06

U.S. RESEARCH ROUNDUP-Brunswick, Parker-Hannifin, XPLR Infrastructure

Reuters
·
Jan 06

UK's Mhra: Approved Zapomeran (Kostaive) Mrna Covid-19 Vaccine, for Immunisation of Individuals Aged 18 Years and Older

THOMSON REUTERS
·
Jan 02

BRIEF-Arcturus Therapeutics Holdings Files For Mixed Shelf Of Up To $500 Million - SEC Filing

Reuters
·
Dec 31, 2025

Arcturus Therapeutics Files $500 Million Mixed Shelf

MT Newswires Live
·
Dec 31, 2025

Arcturus Therapeutics Files Initial Beneficial Ownership Statement for Controller Joseph Roberts

Reuters
·
Dec 20, 2025

BRIEF-Arcturus Therapeutics CFO Andy Sassine To Leave Company

Reuters
·
Dec 15, 2025

Arcturus Therapeutics Holdings Inc - CFO Andy Sassine to Leave Company - SEC Filing

THOMSON REUTERS
·
Dec 15, 2025

Arcturus Therapeutics Updates CFO Severance and Stock Option Terms

Reuters
·
Dec 15, 2025

Arcturus Therapeutics Holdings Inc. reports 59% revenue decline for Q3 2025

Reuters
·
Nov 12, 2025

Arcturus Therapeutics Delays Financial Report Filing

Reuters
·
Nov 12, 2025

Arcturus Therapeutics Q3 Collaboration Revenue USD 14.153 Million

THOMSON REUTERS
·
Nov 11, 2025

Arcturus Therapeutics reports third quarter revenue of $17.2 million and net loss of $13.5 million

Reuters
·
Nov 11, 2025

Arcturus Therapeutics Holdings Inc -Additional Cost Reductions Planned in Q4 to Extend Cash Runway

THOMSON REUTERS
·
Nov 11, 2025

Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress

THOMSON REUTERS
·
Nov 11, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 10, 2025

Arcturus Therapeutics Holdings Inc expected to post a loss of 82 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 07, 2025

Arcturus Therapeutics to Join Guggenheim Healthcare Innovation Conference

Reuters
·
Nov 05, 2025

Press Release: Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025

Dow Jones
·
Oct 29, 2025